Centers for Disease Control. Traumatic brain injury & concussion 2024 [cited 2024 May 10]. https://www.cdc.gov/traumaticbraininjury/data/index.html.

Centers for Disease Control and Prevention. Surveillance report of traumatic brain injury-related emergency department visits, hospitalizations, and deaths-United States, 2014 2019 [cited 2024 August 27]. https://www.cdc.gov/traumaticbraininjury/pdf/TBI-Surveillance-Report-FINAL_508.pdf.

McConeghy KW, Hatton J, Hughes L, Cook AM. A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury. CNS Drugs. 2012;26(7):613–36.

CAS  PubMed  Google Scholar 

Goldstein M. The decade of the brain. Neurology. 1990;40(2):321.

CAS  PubMed  Google Scholar 

Enriquez P, Bullock R. Molecular and cellular mechanisms in the pathophysiology of severe head injury. Curr Pharm Des. 2004;10(18):2131–43.

CAS  PubMed  Google Scholar 

Marmarou A. A review of progress in understanding the pathophysiology and treatment of brain edema. Neurosurg Focus. 2007;22(5):1–10.

Google Scholar 

Schouten JW. Neuroprotection in traumatic brain injury: a complex struggle against the biology of nature. Curr Opin Crit Care. 2007;13(2):134–42.

PubMed  Google Scholar 

Silvestro S, Raffaele I, Quartarone A, Mazzon E. Innovative Insights into traumatic brain injuries: biomarkers and new pharmacological targets. Int J Mol Sci. 2024;25(4):2372.

CAS  PubMed  PubMed Central  Google Scholar 

Overgaard J, Tweed WA. Cerebral circulation after head injury. 1. Cerebral blood flow and its regulation after closed head injury with emphasis on clinical correlations. J Neurosurg. 1974;41(5):531–41.

White BC, Sullivan JM, DeGracia DJ, O'Neil BJ, Neumar RW, Grossman LI, et al. Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J Neurol Sci. 2000;179(S 1-2):1–33.

Lewen A, Matz P, Chan PH. Free radical pathways in CNS injury. J Neurotrauma. 2000;17(10):871–90.

CAS  PubMed  Google Scholar 

Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, et al. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev. 2010;62(3):405–96.

CAS  PubMed  PubMed Central  Google Scholar 

Sullivan PG, Thompson MB, Scheff SW. Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury. Exp Neurol. 1999;160(1):226–34.

CAS  PubMed  Google Scholar 

Cook AM, Whitlow J, Hatton J, Young AB. Cyclosporin A neuroprotection: establishing dosing guidelines for safe and effective use. Expert Opin Drug Saf. 2009;8(4):411–9.

CAS  PubMed  Google Scholar 

Centers for Disease Control and Prevention. Heads up 2024 [cited 2024 January 2]. https://www.cdc.gov/heads-up/index.html.

Cernak I, Noble-Haeusslein LJ. Traumatic brain injury: an overview of pathobiology with emphasis on military populations. J Cereb Blood Flow Metab. 2010;30(2):255–66.

PubMed  Google Scholar 

Long JB, Bentley TL, Wessner KA, Cerone C, Sweeney S, Bauman RA. Blast overpressure in rats: recreating a battlefield injury in the laboratory. J Neurotrauma. 2009;26(6):827–40.

PubMed  Google Scholar 

Armonda RA, Bell RS, Vo AH, Ling G, DeGraba TJ, Crandall B, et al. Wartime traumatic cerebral vasospasm: recent review of combat casualties. Neurosurgery. 2006;59(6):1215–25 (discussion 25).

PubMed  Google Scholar 

Hoge CW, McGurk D, Thomas JL, Cox AL, Engel CC, Castro CA. Mild traumatic brain injury in U.S. soldiers returning from Iraq. N Engl J Med. 2008;358(5):453–63.

CAS  PubMed  Google Scholar 

Wu YC, Wen Q, Thukral R, Yang HC, Gill JM, Gao S, et al. Longitudinal associations between blood biomarkers and white matter MRI in sport-related concussion: a study of the NCAA-DoD CARE consortium. Neurology. 2023;101(2):e189–201.

CAS  PubMed  PubMed Central  Google Scholar 

Clarke GJB, Skandsen T, Zetterberg H, Follestad T, Einarsen CE, Vik A, et al. Longitudinal associations between persistent post-concussion symptoms and blood biomarkers of inflammation and CNS-injury after mild traumatic brain injury. J Neurotrauma. 2024;41(7–8):862–78.

PubMed  Google Scholar 

Patel H, Polam S, Joseph R. Overview of treatment options for mild traumatic brain injury: a literature review. Cureus. 2024;16(4): e59021.

PubMed  PubMed Central  Google Scholar 

Etemad LL, Yue JK, Barber J, Nelson LD, Bodien YG, Satris GG, et al. Longitudinal Recovery following repetitive traumatic brain injury. JAMA Netw Open. 2023;6(9): e2335804.

PubMed  PubMed Central  Google Scholar 

Lubbers VF, van den Hoven DJ, van der Naalt J, Jellema K, van den Brand C, Backus B. Emergency department risk factors for post-concussion syndrome after mild traumatic brain injury: a systematic review. J Neurotrauma. 2024;41(11–12):1253–70.

PubMed  Google Scholar 

Zuckerman SL, Yengo-Kahn AM, Tang AR, Bailes JE, Beauchamp K, Berger MS, et al. Sport-related structural brain injury and return to play: systematic review and expert insight. Neurosurgery. 2021;88(6):E495–504.

PubMed  Google Scholar 

Poon MTC, Al-Shahi SR. Association between antithrombotic drug use before chronic subdural haematoma and outcome after drainage: a systematic review and meta-analysis. Neurosurg Rev. 2018;41(2):439–45.

PubMed  Google Scholar 

Weigel R, Schilling L, Krauss JK. The pathophysiology of chronic subdural hematoma revisited: emphasis on aging processes as key factor. Geroscience. 2022;44(3):1353–71.

PubMed  PubMed Central  Google Scholar 

Bounajem MT, Campbell RA, Denorme F, Grandhi R. Paradigms in chronic subdural hematoma pathophysiology: current treatments and new directions. J Trauma Acute Care Surg. 2021;91(6):e134–41.

PubMed  Google Scholar 

Werner JK, Albrecht J, Capaldi VF, Jain S, Sun X, Mukherjee P, et al. Association of Biomarkers of neuronal injury and inflammation with insomnia trajectories after traumatic brain injury: a TRACK-TBI study. Neurology. 2024;102(8): e209269.

CAS  PubMed  Google Scholar 

Korley FK, Jain S, Sun X, Puccio AM, Yue JK, Gardner RC, et al. Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study. Lancet Neurol. 2022;21(9):803–13.

CAS  PubMed  PubMed Central  Google Scholar 

Wang KKW, Kobeissy FH, Shakkour Z, Tyndall JA. Thorough overview of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein as tandem biomarkers recently cleared by US Food and Drug Administration for the evaluation of intracranial injuries among patients with traumatic brain injury. Acute Med Surg. 2021;8(1): e622.

PubMed  PubMed Central  Google Scholar 

Wang KK, Yang Z, Zhu T, Shi Y, Rubenstein R, Tyndall JA, et al. An update on diagnostic and prognostic biomarkers for traumatic brain injury. Expert Rev Mol Diagn. 2018;18(2):165–80.

PubMed  PubMed Central  Google Scholar 

Shahim P, Politis A, van der Merwe A, Moore B, Chou YY, Pham DL, et al. Neurofilament light as a biomarker in traumatic brain injury. Neurology. 2020;95(6):e610–22.

CAS  PubMed  PubMed Central  Google Scholar 

Roberts I, Shakur H, Coats T, Hunt B, Balogun E, Barnetson L, et al. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess. 2013;17(10):1–79.

CAS  PubMed  PubMed Central  Google Scholar 

Collaborators WT. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017;389(10084):2105–16.

Google Scholar 

Oertel M, Kelly DF, McArthur D, Boscardin WJ, Glenn TC, Lee JH, et al. Progressive hemorrhage after head trauma: predictors and consequences of the evolving injury. J Neurosurg. 2002;96(1):109–16.

PubMed  Google Scholar 

Collaborators C-IBMS. Tranexamic acid in traumatic brain injury: an explanatory study nested within the CRASH-3 trial. Eur J Trauma Emerg Surg. 2021;47(1):261–8.

Crash-trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet. 2019;394(10210):1713–23.

Brenner A, Belli A, Chaudhri R, Coats T, Frimley L, Jamaluddin SF, et al. Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial. Crit Care. 2020;24(1):560.

PubMed  PubMed Central  Google Scholar 

Spani CB, Braun DJ, Van Eldik LJ. Sex-related responses after traumatic brain injury: considerations for preclinical modeling. Front Neuroendocrinol. 2018;50:52–66.

PubMed  PubMed Central  Google Scholar 

Stein DG, Wright DW. Progesterone in the clinical treatment of acute traumatic brain injury. Expert Opin Investig Drugs. 2010;19(7):847–57.

CAS  PubMed  Google Scholar 

Breeding T, Martinez B, Katz J, Nasef H, Santos RG, Zito T, et al. The association between gender and clinical outcomes in patients with moderate to severe traumatic brain injury: a systematic review and meta-analysis. J Surg Res. 2024;295:791–9.

CAS  PubMed  Google Scholar 

Haynes N, Goodwin T. Literature review of sex differences in mTBI. Mil Med. 2023;188(5–6):e978–84.

PubMed  Google Scholar 

Deutsch ER, Espinoza TR, Atif F, Woodall E, Kaylor J, Wright DW. Progesterone’s role in neuroprotection, a review of the evidence. Brain Res. 2013;1530:82–105.

CAS  PubMed